TMCnet News
Hot Stock: CEL-SCI, Shares Drop 14.4% (CVM)Jun 19, 2012 (SmarTrend(R) Spotlight via COMTEX) -- CEL-SCI (AMEX:CVM) is one of today's worst performing penny stocks, down 14.4% to $0.35 on 9.0x average daily volume. Thus far today, CEL-SCI has traded 6.7 million shares, vs. average volume of 747,000 shares per day. The stock has underperformed the Dow (-14.4% to the Dow's 0.9%) and underperformed the S&P 500 (-14.4% to the S&P's 1.0%) during today's trading. In the past 52 weeks, shares of CEL-SCI have traded between a low of $0.27 and a high of $0.65 and are now at $0.35, which is 30% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 0.8%. CEL-SCI Corporation researches and develops certain drugs and vaccines. The Company's Multikine is being tested to determine if it is effective in improving the immune response of cancer patients. CEL-SCI is also developing other products. The Company is currently targeting diseases such as AIDS, herpes simplex, malaria, tuberculosis, prostate cancer, and breast cancer. Potential upside of 469.8% exists for CEL-SCI, based on a current level of $0.35 and analysts' average consensus price target of $2.00. The stock should find initial resistance at its 200-day moving average (MA) of $0.38 and further resistance at its 50-day MA of $0.44. SmarTrend is tracking the current trend status for CEL-SCI and will alert subscribers who have CVM in their portfolio or watchlist when shares have changed trend direction. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |